FOLR1 and cancer: For instance, the variety of folate-conjugated drugs (e.g., low molecular weight cytotoxic agents, anti-sense oligonucleotides, liposomes containing drugs and immunotherapeutic agents) have been successfully delivered to FRα-positive cancer cells [5].